189 related articles for article (PubMed ID: 15365366)
21. Small cell malignant melanoma: a variant of naevoid melanoma. Clinicopathological features and histological differential diagnosis.
Blessing K; Grant JJ; Sanders DS; Kennedy MM; Husain A; Coburn P
J Clin Pathol; 2000 Aug; 53(8):591-5. PubMed ID: 11002761
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma: higher diagnostic accuracy with Melan-A and MART-1 compared with S-100 protein and HMB-45.
Shidham VB; Qi DY; Acker S; Kampalath B; Chang CC; George V; Komorowski R
Am J Surg Pathol; 2001 Aug; 25(8):1039-46. PubMed ID: 11474288
[TBL] [Abstract][Full Text] [Related]
23. Comparison of immunohistochemical staining of the novel antibody melan-A with S100 protein and HMB-45 in malignant melanoma and melanoma variants.
Blessing K; Sanders DS; Grant JJ
Histopathology; 1998 Feb; 32(2):139-46. PubMed ID: 9543670
[TBL] [Abstract][Full Text] [Related]
24. Expression of melanocytic differentiation markers in malignant melanomas of the oral and sinonasal mucosa.
Prasad ML; Jungbluth AA; Iversen K; Huvos AG; Busam KJ
Am J Surg Pathol; 2001 Jun; 25(6):782-7. PubMed ID: 11395556
[TBL] [Abstract][Full Text] [Related]
25. Recurrent melanocytic nevus: a histologic and immunohistochemical evaluation.
Hoang MP; Prieto VG; Burchette JL; Shea CR
J Cutan Pathol; 2001 Sep; 28(8):400-6. PubMed ID: 11493377
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical study of microphthalmia transcription factor and tyrosinase in angiomyolipoma of the kidney, renal cell carcinoma, and renal and retroperitoneal sarcomas: comparative evaluation with traditional diagnostic markers.
Zavala-Pompa A; Folpe AL; Jimenez RE; Lim SD; Cohen C; Eble JN; Amin MB
Am J Surg Pathol; 2001 Jan; 25(1):65-70. PubMed ID: 11145253
[TBL] [Abstract][Full Text] [Related]
27. Analysis of microphthalmia transcription factor expression in normal tissues and tumors, and comparison of its expression with S-100 protein, gp100, and tyrosinase in desmoplastic malignant melanoma.
Busam KJ; Iversen K; Coplan KC; Jungbluth AA
Am J Surg Pathol; 2001 Feb; 25(2):197-204. PubMed ID: 11176068
[TBL] [Abstract][Full Text] [Related]
28. Staining of melanocytic neoplasms by melanoma antigen recognized by T cells.
Mehregan DR; Hamzavi I
Am J Dermatopathol; 2000 Jun; 22(3):247-50. PubMed ID: 10871068
[TBL] [Abstract][Full Text] [Related]
29. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers.
Miettinen M; Fernandez M; Franssila K; Gatalica Z; Lasota J; Sarlomo-Rikala M
Am J Surg Pathol; 2001 Feb; 25(2):205-11. PubMed ID: 11176069
[TBL] [Abstract][Full Text] [Related]
30. Basal cell carcinomas are populated by melanocytes and Langerhans [correction of Langerhan's] cells.
Florell SR; Zone JJ; Gerwels JW
Am J Dermatopathol; 2001 Feb; 23(1):24-8. PubMed ID: 11176048
[TBL] [Abstract][Full Text] [Related]
31. Melan A and S100 protein immunohistochemistry in feline melanomas: 48 cases.
Ramos-Vara JA; Miller MA; Johnson GC; Turnquist SE; Kreeger JM; Watson GL
Vet Pathol; 2002 Jan; 39(1):127-32. PubMed ID: 12102204
[TBL] [Abstract][Full Text] [Related]
32. Expression of S100a, vimentin, NSE, and melan A/MART-1 in seven canine melanoma cells lines and twenty-nine retrospective cases of canine melanoma.
Koenig A; Wojcieszyn J; Weeks BR; Modiano JF
Vet Pathol; 2001 Jul; 38(4):427-35. PubMed ID: 11467477
[TBL] [Abstract][Full Text] [Related]
33. Melan-A, a new melanocytic differentiation marker.
Busam KJ; Jungbluth AA
Adv Anat Pathol; 1999 Jan; 6(1):12-8. PubMed ID: 10197235
[TBL] [Abstract][Full Text] [Related]
34. Melanoma markers in angiomyolipoma of the liver and kidney: a comparative study.
Makhlouf HR; Ishak KG; Shekar R; Sesterhenn IA; Young DY; Fanburg-Smith JC
Arch Pathol Lab Med; 2002 Jan; 126(1):49-55. PubMed ID: 11800647
[TBL] [Abstract][Full Text] [Related]
35. A quantitative immunohistochemical evaluation of lentigo maligna and pigmented solar keratosis.
Lane H; O'Loughlin S; Powell F; Magee H; Dervan PA
Am J Clin Pathol; 1993 Dec; 100(6):681-5. PubMed ID: 8249917
[TBL] [Abstract][Full Text] [Related]
36. Microphthalmia transcription factor: a sensitive and specific marker for malignant melanoma in cytologic specimens.
Dorvault CC; Weilbaecher KN; Yee H; Fisher DE; Chiriboga LA; Xu Y; Chhieng DC
Cancer; 2001 Oct; 93(5):337-43. PubMed ID: 11668469
[TBL] [Abstract][Full Text] [Related]
37. Melanoma in situ versus melanocytic hyperplasia in sun-damaged skin. Assessment of the significance of histopathologic criteria for differential diagnosis.
Weyers W; Bonczkowitz M; Weyers I; Bittinger A; Schill WB
Am J Dermatopathol; 1996 Dec; 18(6):560-6. PubMed ID: 8989926
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of melanocytic neoplasms: application of a pan-melanoma antibody cocktail.
Orchard G
Br J Biomed Sci; 2002; 59(4):196-202. PubMed ID: 12572952
[TBL] [Abstract][Full Text] [Related]
39. Melan-A as a useful diagnostic immunohistochemical stain for the diagnosis of primary sinonasal melanomas.
Snyder ML; Paulino AF
Head Neck; 2002 Jan; 24(1):52-5. PubMed ID: 11774402
[TBL] [Abstract][Full Text] [Related]
40. Mel-5: a novel antibody for differential diagnosis of epidermal pigmented lesions of the skin in paraffin-embedded sections.
Bhawan J
Melanoma Res; 1997 Feb; 7(1):43-8. PubMed ID: 9067964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
